Article Information
History
- July 11, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Michael J. Peluso1,^,
- Scott Lu2,
- Alex F. Tang1,
- Matthew S. Durstenfeld3,
- Hsi-en Ho4,
- Sarah A. Goldberg2,
- Carrie A. Forman1,
- Sadie E. Munter5,
- Rebecca Hoh1,
- Viva Tai1,
- Ahmed Chenna6,
- Brandon C. Yee6,
- John W. Winslow6,
- Christos J. Petropoulos6,
- Bryan Greenhouse1,
- Peter W. Hunt5,
- Priscilla Y. Hsue3,
- Jeffrey N. Martin2,
- J. Daniel Kelly2,
- David V. Glidden2,
- Steven G. Deeks1,* and
- Timothy J. Henrich5,*
- 1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, CA, USA
- 2Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA
- 3Division of Cardiology, University of California, San Francisco, CA, USA
- 4Icahn School of Medicine at Mount Sinai, New York, NY, USA
- 5Division of Experimental Medicine, University of California, San Francisco, CA, USA
- 6Monogram Biosciences Inc., South San Francisco, CA, USA
- ↵^To whom correspondence should be addressed: Michael J. Peluso, MD, 995 Potrero Ave., San Francisco, CA 94110, michael.peluso{at}ucsf.edu
↵* Contributed equally
Posted July 11, 2021.
Markers of immune activation and inflammation in individuals with post-acute sequelae of SARS-CoV-2 infection
